Abstract
Gut microbiota have a variety of health and nutritional benefits in their host organisms. Their beneficial effects are related to gastrointestinal diseases, immunomodulation, intestinal microbial balance, and antimicrobial properties. However, their properties also involve an influence on the bioavailability of certain drugs and food components in the body. Phytoestrogens are nonsteroidal secondary metabolites with estrogenic activity. They are found in various foods, especially soy, and are used for the treatment of estrogen-associated diseases such as menopause, cardiovascular diseases, breast cancer, and osteoporosis. Some metabolites produced by gut microbiota from phytoestrogens have even stronger effects due to their higher lipophilicity, which leads to a better absorption and a higher affinity with estrogen receptors. The crucial metabolism of phytoestrogens takes place in the gastrointestinal tract where the gut microbiota are present. Probiotics are live microorganisms that can confer health benefits to the host when administered in adequate amounts. They are present in milk products and dietary supplements, and are capable of restoring the gut microbial communities when ingested. Most of the probiotics are bacteria and thus their intake can enhance the metabolism of phytoestrogens and, therefore, enhance their pharmacological effects. In this review, we summarize the influence of gut microbiota on the metabolism of phytoestrogens and their beneficial effects on the host.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are openly available.
References
Adlercreutz H, Mazur W (1997) Phyto-oestrogens and western diseases. Ann Med 29:95–120
Amarowicz R, Pegg RB (2019) Natural antioxidants of plant origin. In: Ferreria I, Barros L (eds) Advances in food and nutrition research. Functional food ingredients from plants. Academic, Cambridge, pp 1–81. https://doi.org/10.1016/bs.afnr.2019.02.011
Athni TS, Athni SS (2019) The evolution of modern medicine: garden to pill box. In: Joshee N, Dhekney S, Parajuli P (eds) Medicinal Plants. Springer, Cham, pp 1–16. https://doi.org/10.1007/978-3-030-31269-5_1
Bacciottini L, Falchetti A, Pampaloni B, Bartolini E, Carossino AM, Brandi ML (2007) Phytoestrogens: food or drug? Clin Cases Miner Bone Metab 4:123–130
Baker JM, Nakkash LA, Herbst-Kralovetz MM (2017) Estrogen–gut microbiome axis: physiological and clinical implications. Maturitas 103:45–53
Basu P, Maier C (2018) Phytoestrogens and breast cancer: in vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives. Biomed Pharmacother 107:1648–1666. https://doi.org/10.1016/j.biopha.2018.08.100
Bilal I, Chowdhury A, Davidson J, Whitehead S (2014) Phytoestrogens and prevention of breast cancer: the contentious debate. World J Clin Oncol 5:705–712
Bravo D, Peiroten A, Alvarez I, Landete JM (2017) Phytoestrogen metabolism by lactic acid bacteria: enterolignan production by Lactobacillus salivarius and Lactobacillus gasseri strains. J Funct Foods 37:373–378
Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J (2010) Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92:141–153
Canny GO, McCormick BA (2008) Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 76:3360–3373
Cerda B, Tomas-Barberan FA, Espin JC (2005) Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 53:227–235
Chen MN, Lin CC, Liu CF (2015) Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric 18:260–269
Clavel T, Dore J, Blaut M (2006a) Bioavailability of lignans in human subjects. Nutr Res Rev 19:187–196
Clavel T, Borrmann D, Braune A, Doré J, Blaut M (2006b) Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 12:140–147
Creus-Cuadros A, Tresserra-Rimbau A, Quifer-Rada P, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Estruch R, Gómez-Gracia E, Lapetra J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Moreno JJ, Ruiz-Canela M, Sorli JV, Basora J, Schröder H, Lamuela-Raventós RM, PREDIMED Study Investigators (2017) Associations between both lignan and yogurt consumption and cardiovascular risk parameters in an elderly population: observations from a cross-sectional approach in the PREDIMED study. J Acad Nutr Diet 117:609–622. https://doi.org/10.1016/j.jand.2016.11.003
Desmawati D, Sulastri D (2019) Phytoestrogens and their health effect. Open Access Maced J Med Sci 7:495–499. https://doi.org/10.3889/oamjms.2019.086
Di Cagno R, Mazzacane F, Rizello CG, Vincentini O, Silano M, Giuliano G, De Angelis M, Gobbetti M (2010) Synthesis of isoflavone aglycones and equol in soy milks fermented by food-related lactic acid bacteria and their effect on human intestinal Caco-2 cells. J Agric Food Chem 58:10338–10346
Ding WK, Shah NP (2010) Enhancing the biotransformation of isoflavones in soymilk supplemented with lactose using probiotic bacteria during extended fermentation. J Food Sci 75:M140–M149
Donkor ON, Shah NP (2007) Production of β-glucosidase and hydrolysis of isoflavone phytoestrogens by Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei in soymilk. J Food Sci 73:M15–M20
Eisenbrand G, Senate Commission on Food Safety of the German Research F (2007) Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG)-(shortened version). Mol Nutr Food Res 51:1305–1312
Espin JC, Larrosa M, Garcia-Conesa MT, Tomas-Barberan F (2013) Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. https://doi.org/10.1155/2013/270418
Frankenfeld CL (2016) Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes. Mol Nutr Food Res. https://doi.org/10.1002/mnfr.201500900
Freeman EW, Sherif K (2007) Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 10:197–214
Gaya P, Medina M, Sanchez-Jimenez A, Landete JM (2016a) Phytoestrogen metabolism by adult human gut microbiota. Molecules. https://doi.org/10.3390/molecules21081034
Gaya P, Peiroten A, Medina M, Landete JM (2016b) Isoflavone metabolism by a collection of lactic acid bacteria and bifidobacteria with biotechnological interest. Int J Food Sci Nutr 67:117–124
Gencel VB, Benjamin MM, Bahou SN, Khalil RA (2012) Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini-Rev Med Chem 12:149–174
Hasaniani N, Rahimlou M, Ramezani Ahmadi A, Mehdizadeh Khalifani A, Alizadeh M (2019) The effect of flaxseed enriched yogurt on the glycemic status and cardiovascular risk factors in patients with type 2 diabetes mellitus: randomized, open-labeled, controlled study. Clin Nutr Res 8:284–295. https://doi.org/10.7762/cnr.2019.8.4.284
Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T, Nishibe S, Adlercreutz H (2001) In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49:3178–3186
Hur HG, Lay JO, Beger RD, Freeman JP, Rafii F (2000) Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Arch Microbiol 174:422–428
Iqbal MF, Zhu WY (2009) Characterization of newly isolated Lactobacillus delbrueckii-like strain MF-07 isolated from chicken and its role in isoflavone biotransformation. FEMS Microbiol Lett 291:180–187
Ismail T, Calcabrini C, Diaz AR, Fimognari C, Turrini E, Catanzaro E, Akhtar S, Sestili P (2016) Ellagitannins in cancer chemoprevention and therapy. Toxins. https://doi.org/10.3390/toxins8050151
Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H (2002) Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155:472–477
Lambert MNT, Thybo CB, Lykkeboe S, Rasmussen LM, Frette X, Christensen LP, Jeppesen PB (2017) Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial. Am J Clin Nutr 106:909–920
Lampe JW (2003) Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133(Suppl 3):956S–964S
Landete JM, Arques J, Medina M, Gaya P, de Las RB, Munoz R (2016) Bioactivation of phytoestrogens: intestinal bacteria and health. Crit Rev Food Sci 56:1826–1843
Landete JM, Gaya P, Rodriguez E, Langa S, Peiroten A, Medina M, Arques JL (2017) Probiotic bacteria for healthier aging: immunomodulation and metabolism of phytoestrogens. Biomed Res. https://doi.org/10.1155/2017/5939818
Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT (2009) The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 10:3755–3775
Muñoz O, Fuentealba C, Ampuero D, Figuerola F, Estevez AM (2018) The effect of Lactobacillus acidophilus and Lactobacillus casei on the in vitro bioaccessibility of flaxseed lignans (Linum usitatissimum L.). Food Funct 9:2426–2432. https://doi.org/10.1039/c8fo00390d
Nakatsu CH, Armstrong A, Clavijo AP, Martin BR, Barnes S, Weaver CM (2014) Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS One. https://doi.org/10.1371/journal.pone.0108924
Otieno DO, Ashton JF, Shah NP (2006) Evaluation of enzymic potential for biotransformation of isoflavone phytoestrogen in soymilk by Bifidobacterium animalis, Lactobacillus acidophilus and Lactobacillus casei. Food Res Int 39:394–407
Parikh M, Maddaford TG, Austria JA, Aliani M, Netticadan T, Pierce GN (2019) Dietary flaxseed as a strategy for improving human health. Nutrients. https://doi.org/10.3390/nu11051171
Patisaul HB, Jefferson W (2010) The pros and cons of phytoestrogens. Front Neuroendocrinol 31:400–419
Patridge E, Gareiss P, Kinch MS, Hoyer D (2016) An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today 21:204–207
Peirotén A, Gaya P, Alvarez I, Bravo D, Landete JM (2019a) Influence of different lignan compounds on enterolignan production by Bifidobacterium and Lactobacillus strains. Int J Food Microbiol 289:17–23. https://doi.org/10.1016/j.ijfoodmicro.2018.08.028
Peirotén A, Bravo D, Landete JM (2019b) Bacterial metabolism as responsible of beneficial effects of phytoestrogens on human health. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2019.1622505
Pessione E (2012) Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2012.00086
Piwowarski JP, Granica S, Stefanska J, Kisst AK (2016) Differences in metabolism of ellagitannins by human gut microbiota ex vivo cultures. J Nat Prod 79:3022–3030
Puupponen-Pimia R, Seppanen-Laakso T, Kankainen M, Maukonen J, Torronen R, Kolehmainen M, Leppanen T, Moilanen E, Nohynek L, Aura AM, Poutanen K, Tomas-Barberan FA, Espin JC, Oksman-Caldentey KM (2013) Effects of ellagitannin-rich berries on blood lipids, gut microbiota, and urolithin production in human subjects with symptoms of metabolic syndrome. Mol Nutr Food Res 57:2258–2263
Rietjens I, Louisse J, Beekmann K (2017) The potential health effects of dietary phytoestrogens. Br J Pharmacol 174:1263–1280
Rodríguez-García C, Sánchez-Quesada C, Toledo E, Delgado-Rodríguez M, Gaforio JJ (2019) Naturally lignan-rich foods: a dietary tool for health promotion? Molecules. https://doi.org/10.3390/molecules24050917
Selma MV, Beltran D, Garcia-Villalba R, Espin JC, Tomas-Barberan FA (2014) Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species. Food Funct 5:1779–1784
Selma MV, Beltran D, Luna MC, Romo-Vaquero M, Garcia-Villalba R, Mira A, Espin JC, Tomas-Barberan FA (2017) Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Front Microbiol. https://doi.org/10.3389/fmicb.2017.01521
Setchell KD, Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S–609S
Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ (2003) Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78:123–130
Sun Q, Wedick NM, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM (2014) Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care 37:1287–1295
Talaei M, Pan A (2015) Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes 6:271–283
Tamura M, Hori S, Nakagawa H (2011) Lactobacillus rhamnosus JCM 2771: impact on metabolism of isoflavonoids in the fecal flora from a male equol producer. Curr Microbiol 62:1632–1637
Tham DM, Gardner CD, Haskell WL (1998) Clinical review 97: potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83:2223–2235
Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823–1836
Tsuchihashi R, Sakamoto S, Kodera M, Nohara T, Kinjo J (2008) Microbial metabolism of soy isoflavones by human intestinal bacterial strains. J Nat Med Tokyo 62:456–460
Uchiyama S, Ueno T, Suzuki T (2007) Identification of a newly isolated equol-producing lactic acid bacterium from the human feces. J Intest Microbiol 21:217–220
Yoder SC, Lancaster SM, Hullar MAJ, Lampe JW (2015) Gut microbial metabolism of plant lignans: influence on human health. In: Tuohy K, Rio DD (eds) Diet-microbe interactions in the gut effects on human health and disease. Academic, Cambridge, pp 103–117
Zhang S, Maghout TA, Cao H, Pelzl L, Salker MS, Veldhoen M, Cheng A, Lang F, Singh Y (2019) Gut bacterial metabolite urolithin A (UA) mitigates Ca2+ entry in T cells by regulating miR-10a-5p. Front Immunol. https://doi.org/10.3389/fimmu.2019.01737
Acknowledgments
The authors are grateful to Mr. Karsten Fatur for his proof reading as a native speaker and a scientist.
Funding
For this research, the authors did not receive any extra founding. Research was founded by the organizations, where the authors are affiliated: University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia and Jožef Stefan Institute, Department of Biotechnology, Ljubljana, Slovenia.
Author information
Authors and Affiliations
Contributions
SS (PhD student) wrote the first draft of the manuscript. SK revised the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Stojanov, S., Kreft, S. Gut Microbiota and the Metabolism of Phytoestrogens. Rev. Bras. Farmacogn. 30, 145–154 (2020). https://doi.org/10.1007/s43450-020-00049-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-020-00049-x